Heavyweight M&A Firms Take On $5.9 Billion Pharma Takeover Bid
The unsolicited bid reunites former M&A colleagues Eric Krautheimer and Matthew Hurd with debt expert Neil George Weiand
March 01, 2019 at 09:29 AM
2 minute read
Sullivan & Cromwell, Linklaters and Simpson Thacher & Bartlett have picked up mandates on the $5.9 billion hostile takeover bid launched earlier this week by German pharmaceuticals giant Merck for U.S. chemicals manufacturer Versum Materials.
The offer comes a month after U.S. manufacturer Entegris previously proposed to merge with Versum Materials to create a combined company with a market valuation of about $9 billion, according to Entegris.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 2BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 3The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 4The Growing Tension—And Opportunity—in Big Law Nonequity Tiers
- 5The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250